Table 2.
Univariate and multivariate analysis of risk factors of PT
| Risk factors | Univariate analysis of P value* | Multivariate analysis | ||
|---|---|---|---|---|
| OR | 95 % Cl | P value** | ||
| Demographics | ||||
| Gender, female vs. male | .580 | |||
| Age, per decade | .103 | |||
| Disease characteristics | ||||
| Diagnosis, acute leukemia vs. other | .070 | |||
| Transplantation characteristics | ||||
| Donor type, PMRD vs. others | .246 | |||
| Status, high risk vs. standard risk | .967 | |||
| Transplantation-related complications | ||||
| History of severe GvHD | .017 | 4.056 | 1.171–14.050 | .027 |
| CMV infection after HSCT | .016 | |||
| Desialylation levels | ||||
| MFI of SNAa | <.001 | 8.137 | 2.364–28.005 | .001 |
Abbreviations: OR odds ratio, CI confidence interval, HSCT hematopoietic stem cell transplantation, PT prolonged isolated thrombocytopenia, PMRD partially matched related donor, GvHD graft-versus-host disease, CMV cytomegalovirus
*P < .10 in univariate analysis; **P < .05 in multivariate analysis
aThe MFI of SNA was separated into 2 groups according to the receiver operating characteristic (ROC) cutoff point (23.5)